BioNTech SE (22UA.DE) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close79.40

Open80.05

Day range80.0581.35

52-week range68.30105.70

Off day high−0.55%

Off 52-week high−23.46%

Volume10.51K

Avg. volume (3M)38.33K

Market cap20.06B

EPS (TTM)-5.88

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)1.33

Shares outstanding247.93M

Short interest—

Earnings dateNov 3, 2026

Analyst target—

Profit margin−63.64%

Against its peers

Compare in full ›

	22UA.DE	688382.SS	ROIV	6IB.F	GMAB	1875.HK
Market cap	20.06B	8.38B	27.61B	17.27B	33.89B	2.56B
P/E (TTM)	—	—	—	123.8	43.4	—
Forward P/E	—	-43.8	-27.5	—	34.9	42.9
Price/book	1.1	6.6	6.5	6.2	5.5	3.8
Dividend yield	—	—	—	—	—	—
1-year change	−14.32%	−48.70%	+85.85%	−1.76%	+91.12%	+69.54%
Today	+1.89%	+4.33%	+6.08%	+3.42%	−0.72%	+5.54%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to BioNTech's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%
Roivant Sciences Ltd.ROIV · Biotechnology	27.61B	38.23	+6.08%
Innovent Biologics, Inc.6IB.F · Biotechnology	17.27B	9.91	+3.42%
Genmab A/SGMAB · Biotechnology	33.89B	55.12	−0.72%
BioDlink International Company Limited1875.HK · Biotechnology	2.56B	3.525	+5.54%
Vir Biotechnology, Inc.VIR · Biotechnology	1.99B	11.77	+4.90%
BioInvent International AB (publ)BINV.ST · Biotechnology	246.77M	3.7500	+4.60%
BioArctic AB (publ)B9A.F · Biotechnology	2.45B	27.58	−0.29%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Keymed Biosciences Inc.2162.HK · Chengdu, China	20.67B	70.150	+2.48%
InnoCare Pharma Limited9969.HK · Beijing, China	21.56B	12.200	+1.33%
WuXi Biologics (Cayman) Inc.1FW1.F · Wuxi, China	22.64B	11.00	−0.90%
Bavarian Nordic A/SBAVA.CO · Hellerup, Denmark	18.58B	249.00	+0.89%
Daesung Microbiological Labs. Co., Ltd.036480.KQ · Uiwang-si, South Korea	19.61B	5,160.00	−4.62%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MA Odds	21.57B	161.08	+0.74%
Zai Lab Limited9688.HK · Pudong, China	22.56B	18.170	+0.89%
InSilico Medicine Cayman TopCo3696.HK · Hong Kong, Hong Kong	22.80B	39.380	0.00%

Healthcare companies of a similar market value (19.63B).

Company	Mkt cap	Price	Today
Keymed Biosciences Inc.2162.HK · Biotechnology	20.67B	70.150	+2.48%
Seoul Pharma Co., Ltd018680.KQ · Drug Manufacturers - Specialty & Generic	19.81B	1,699.00	0.00%
Terumo CorporationTUO.F · Medical Devices	21.09B	14.30	+8.79%
Eurofins Scientific SE0MV5.IL · Diagnostics & Research	19.81B	88.88	+1.00%
InnoCare Pharma Limited9969.HK · Biotechnology	21.56B	12.200	+1.33%
Hybio Pharmaceutical Co., Ltd.300199.SZ · Drug Manufacturers - Specialty & Generic	21.97B	24.87	+9.51%
Indoco Remedies LimitedINDOCO.BO · Drug Manufacturers - Specialty & Generic	19.77B	214.50	+0.14%
Hester Biosciences LimitedHESTERBIO.BO · Drug Manufacturers - Specialty & Generic	20.58B	2,419.55	+4.34%

Also based in Mainz, Germany, then elsewhere in Germany.

Company	Mkt cap	Price	Today
Quantum Cyber N.V.QUCY · Mainz, Germany	64.80M	0.7430	+2.65%
SAP SESAP · Walldorf, Germany	277.06B	240.04	+4.22%
Bayer AktiengesellschaftBAYA.F · Leverkusen, Germany	53.84B	13.70	+3.01%
BASF SEBASF.BD · Ludwigshafen am Rhein, Germany	17.32T	20,120.00	+2.98%
Bayerische Motoren Werke AktiengesellschaftBMW.BD · Munich, Germany	11.85T	20,040.00	−9.16%
Siemens AktiengesellschaftSIE.F · Munich, Germany	212.30B	277.80	+0.33%
Volkswagen AGVOW3N.MX · Wolfsburg, Germany	722.80B	1,441.86	0.00%
Allianz SEALV.F · Munich, Germany	177.20B	467.20	+1.81%

The stocks whose daily moves over the past year went most closely with BioNTech's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
BioNTech SE22UA.F · Correlation 0.87	20.23B	81.60	+2.64%
Moderna, Inc.0QF.DE · Correlation 0.51	91.54B	229.30	+4.13%
Moderna, Inc.0QF.F · Correlation 0.42	91.43B	229.00	+0.88%
Vir Biotechnology, Inc.VIR · Correlation 0.32	1.99B	11.77	+4.90%

What visitors to BioNTech's page also look at.

Company	Mkt cap	Price	Today
PFIZER INC.PFE.DE	157.40B	27.62	+1.58%
BioNTech SE22UA.F	20.23B	81.60	+2.64%
Moderna Inc.0QF.DE	91.54B	229.30	+4.13%
MICROSOFT CORP.MSF.DE	3.68T	495.45	+0.27%
Moderna Inc.0QF.F	91.43B	229.00	+0.88%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 22UA.DE news ›

Seeking Alpha·22h agoNegative

BioNTech Q3: Bristol Myers Revenue Masks A Narrowing Oncology Bet (Rating Downgrade)

BioNTech earns a Hold rating as cash burn, pipeline narrowing, and two-asset concentration raise risk. Click here to read an analysis of BNTX stock now. - BioNTech is rated Hold due to a narrowing pipeline, negative cash flow, and reliance…

BMY

Seeking Alpha·1d agoPositive

BioNTech outlines 2026 revenue guidance of €1.7B-€1.9B as it anticipates gotistobart interim analysis before year-end

BioNTech Q3 2026 earnings: raised revenue guidance, oncology pipeline progress, and key trial risks. Earnings Call Insights: BioNTech (BNTX) Q3 2026 CEO Ugur Sahin said, “We have made good progress against our strategic milestones set out…

BIIB BNTX PFE BMY

Seeking Alpha·1d ago

BioNTech SE (BNTX) Q3 2026 Earnings Call Transcript

BioNTech SE (BNTX) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Douglas Maffei - Vice President of Strategy & Investor RelationsUgur Sahin - Co-Founder, CEO & Chair of the Management BoardÖzlem Türeci - Co-Founder, Chief Medical…

BNTX WFC

GenomeWeb·1d ago

After mRNA Trial Setbacks, BioNTech Still Pushing Ahead in Cancer

Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies GenomeWeb Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies

MRNA PFE LLY

TradingView·1d agoNegative

BioNTech: Higher FY revenue guidance and advancing oncology trials offset pipeline and demand uncertainties

TradingView BioNTech: Higher FY revenue guidance and advancing oncology trials offset pipeline and demand uncertainties Q3 revenue declined as COVID-19 vaccine demand fell, but stronger partn

BNTX NVDA BIIB SPCX

Pluang·1d agoPositive

BioNTech reports Q3 2026 revenues of €1.29B, advances oncology pipeline, raises 2026 revenue guidance

BioNTech announced its third quarter 2026 financial results with revenues of €1.29 billion, driven by ongoing COVID-19 vaccine sales despite lower demand. The company highlighted progress in its oncology pipeline, including new Phase 3…

BNTX BIIB PFE

The Globe and Mail·2d ago

J.P. Morgan Sticks to Their Hold Rating for BioNTech SE (BNTX)

J.P. Morgan analyst Jessica Fye maintained a Hold rating on BioNTech SE today and set a price target of $86.86. According to TipRanks, Fye is a 4-star analyst with an average return of 4.1% and a 52.20% success rate. Fye covers the…

BNTX JEF

Stock Titan·2d ago·2 outletsNegative

BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal…

SPCX NVDA BIIB BBNX

BioNTech's Q3 revenue falls on lower COVID-19 vaccine demand

TradingView BioNTech's Q3 revenue falls on lower COVID-19 vaccine demand

BNTX PFE UNH SNY

TradingView·2d agoPositive

BioNTech: Q3 profitability and higher R&D guidance accompanied an accelerating oncology pipeline

TradingView BioNTech: Q3 profitability and higher R&D guidance accompanied an accelerating oncology pipeline Q3 revenue was €1.289 billion and adjusted net profit was €441 million, with results driven b

BNTX BIIB SPCX NVDA

From the 4Search news index, newest first.

In the news

76mentions in 30 days

76with it in the headline

Mixedsentiment

Most coverage from

marketscreener.com17
markets.businessinsider.com9
247wallst.com8
themarketsdaily.com6
stocktitan.net5

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 76 articles, not a forecast.

Key statistics

Against its peers

Related companies

Latest news

In the news

Mentioned with

People in the coverage

Themes

Most coverage from